pharmaceutical-investing Conatus Announces Completion of Enrollment in ENCORE-LF Phase 2b Clinical Trial of Emricasan
Rio Silver Launches Metallurgical Program to De-Risk Processing and Optimize Silver Recoveries at Maria Norte